Richard W.M. van der Maazen

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma

Michael Schaapveld, Berthe M.P. Aleman, Anna M. van Eggermond et al. · New England Journal of Medicine · 2015 · 626 citations · Full text

Medicine, Oncology, Cancer Control +13

Involved-Field Radiotherapy for Advanced Hodgkin's Lymphoma

Berthe M.P. Aleman, John Raemaekers, Umberto Tirelli et al. · New England Journal of Medicine · 2003 · 307 citations · Full text

Medicine, Oncology, Radiation Oncology +11

A randomized controlled clinical trial on the efficacy of radiation therapy in the control of subfoveal choroidal neovascularization in age-related macular degeneration: radiation versus observation

G. J. Bergink, Carel B. Hoyng, Richard W.M. van der Maazen et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 1998 · 133 citations

Medicine, Ophthalmology, Radiation Oncology +17

Reirradiation of primary brain tumours: survival, clinical response and prognostic factors

Theo Veninga, Ben J. Slotman, E.H.J.M. Rutten et al. · Radiotherapy and Oncology · 2001 · 116 citations

Medicine, Oncology, Radiation Oncology +9

Radiation therapy for subfoveal choroidal neovascular membranes in age-related macular degeneration

G. J. Bergink, August F. Deutman, J.F.C.M. van den Broek et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 1994 · 116 citations

Medicine, Oncology, Ophthalmology +16